A podcast on next-generation immunotherapy developments against cancer.
Dr. O’Day is the Chief Medical Officer of Agenus and a global leader in immuno-oncology. As a clinician, he pioneered CTLA-4 inhibition and its treatment breakthroughs. Steven joined Agenus to bring next-generation immunotherapies to patients.
The number of free subscribers for The Immuno-Oncology Curve with Dr. Steven O'Day over time since it was added to the directory.